1
|
Shields M, Guzman I, Rouse J, Siddiqi A, Pletcher MJ, Khatib R. Adoption of self-measured blood pressure monitoring in underserved communities: Program evaluation in primary care. J Eval Clin Pract 2024. [PMID: 39155625 DOI: 10.1111/jep.14130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2024] [Revised: 07/29/2024] [Accepted: 08/04/2024] [Indexed: 08/20/2024]
Abstract
RATIONALE Self-measured blood pressure (SMBP) monitoring is crucial for hypertension management, yet its adoption, particularly among disadvantaged populations, remains low. 'Love Your Heart' is a quality improvement program providing free standard SMBP devices to hypertensive patients, aiming to enhance adoption and assess its impact on blood pressure control. AIMS AND OBJECTIVES This study evaluates the 'Love Your Heart' program's implementation success through assessing adoption rates and exploring changes in systolic blood pressure (SBP) among participants. We aim to understand factors influencing adoption and potential benefits of SMBP monitoring in a diverse, socially disadvantaged patient population. METHODS We retrospectively evaluated the 'Love Your Heart' program using electronic health records (EHR) at a primary care site in Chicago. Adult patients with hypertension were enroled in the 6-month program, which included education sessions and free SMBP devices. Adoption was measured by participation in program components, and changes in SBP were analysed based on adoption status. Statistical analyses were conducted using SAS software, adhering to STROBE reporting guidelines. RESULTS Of 621 eligible patients, 104 participated, with 83 included in the evaluation. Despite all participants receiving free SMBP devices, adoption rates were modest, with only 7% sharing readings with the care team. However, patients who received device instructions demonstrated greater decreases in SBP compared to those who did not. Although not statistically significant, clinically meaningful decreases in SBP were observed among adopters. CONCLUSION The 'Love Your Heart' program highlights the challenges of promoting SMBP monitoring among disadvantaged patient populations. While providing free devices addresses access barriers, low reporting to the care team suggests the need for further support mechanisms. Future research should explore strategies to enhance SMBP adoption and integration into clinical care, particularly in settings lacking automated data transmission systems.
Collapse
Affiliation(s)
- Maureen Shields
- Advocate Aurora Research Institute, Milwaukee, Wisconsin, USA
| | - Iridian Guzman
- Advocate Aurora Research Institute, Milwaukee, Wisconsin, USA
| | | | | | - Mark J Pletcher
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
| | - Rasha Khatib
- Advocate Aurora Research Institute, Milwaukee, Wisconsin, USA
| |
Collapse
|
2
|
Buis LR, Kim J, Sen A, Chen D, Dawood K, Kadri R, Muladore R, Plegue M, Richardson CR, Djuric Z, McNaughton C, Hutton D, Robert LP, Park SY, Levy P. The Effect of an mHealth Self-Monitoring Intervention (MI-BP) on Blood Pressure Among Black Individuals With Uncontrolled Hypertension: Randomized Controlled Trial. JMIR Mhealth Uhealth 2024; 12:e57863. [PMID: 38941601 PMCID: PMC11245662 DOI: 10.2196/57863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Revised: 04/12/2024] [Accepted: 04/30/2024] [Indexed: 06/30/2024] Open
Abstract
BACKGROUND Hypertension is one of the most important cardiovascular disease risk factors and affects >100 million American adults. Hypertension-related health inequities are abundant in Black communities as Black individuals are more likely to use the emergency department (ED) for chronic disease-related ambulatory care, which is strongly linked to lower blood pressure (BP) control, diminished awareness of hypertension, and adverse cardiovascular events. To reduce hypertension-related health disparities, we developed MI-BP, a culturally tailored multibehavior mobile health intervention that targeted behaviors of BP self-monitoring, physical activity, sodium intake, and medication adherence in Black individuals with uncontrolled hypertension recruited from ED and community-based settings. OBJECTIVE We sought to determine the effect of MI-BP on BP as well as secondary outcomes of physical activity, sodium intake, medication adherence, and BP control compared to enhanced usual care control at 1-year follow-up. METHODS We conducted a 1-year, 2-group randomized controlled trial of the MI-BP intervention compared to an enhanced usual care control group where participants aged 25 to 70 years received a BP cuff and hypertension-related educational materials. Participants were recruited from EDs and other community-based settings in Detroit, Michigan, where they were screened for initial eligibility and enrolled. Baseline data collection and randomization occurred approximately 2 and 4 weeks after enrollment to ensure that participants had uncontrolled hypertension and were willing to take part. Data collection visits occurred at 13, 26, 39, and 52 weeks. Outcomes of interest included BP (primary outcome) and physical activity, sodium intake, medication adherence, and BP control (secondary outcomes). RESULTS We obtained consent from and enrolled 869 participants in this study yet ultimately randomized 162 (18.6%) participants. At 1 year, compared to the baseline, both groups showed significant decreases in systolic BP (MI-BP group: 22.5 mm Hg decrease in average systolic BP and P<.001; control group: 24.1 mm Hg decrease and P<.001) adjusted for age and sex, with no significant differences between the groups (time-by-arm interaction: P=.99). Similar patterns where improvements were noted in both groups yet no differences were found between the groups were observed for diastolic BP, physical activity, sodium intake, medication adherence, and BP control. Large dropout rates were observed in both groups (approximately 60%). CONCLUSIONS Overall, participants randomized to both the enhanced usual care control and MI-BP conditions experienced significant improvements in BP and other outcomes; however, differences between groups were not detected, speaking to the general benefit of proactive outreach and engagement focused on cardiometabolic risk reduction in urban-dwelling, low-socioeconomic-status Black populations. High dropout rates were found and are likely to be expected when working with similar populations. Future work is needed to better understand engagement with mobile health interventions, particularly in this population. TRIAL REGISTRATION ClinicalTrials.gov NCT02955537; https://clinicaltrials.gov/study/NCT02955537. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) RR2-10.2196/12601.
Collapse
Affiliation(s)
- Lorraine R Buis
- Department of Family Medicine, University of Michigan, Ann Arbor, MI, United States
| | - Junhan Kim
- School of Information, University of Michigan, Ann Arbor, MI, United States
| | - Ananda Sen
- Department of Family Medicine, University of Michigan, Ann Arbor, MI, United States
- Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States
| | - Dongru Chen
- Department of Family Medicine, University of Michigan, Ann Arbor, MI, United States
| | - Katee Dawood
- Department of Emergency Medicine and Integrative Biosciences Center, Wayne State University, Detroit, MI, United States
| | - Reema Kadri
- Department of Family Medicine, University of Michigan, Ann Arbor, MI, United States
| | - Rachelle Muladore
- Department of Emergency Medicine and Integrative Biosciences Center, Wayne State University, Detroit, MI, United States
| | - Melissa Plegue
- Department of Pediatrics, University of Michigan, Ann Arbor, MI, United States
| | - Caroline R Richardson
- Department of Family Medicine, University of Michigan, Ann Arbor, MI, United States
- Department of Family Medicine, Brown University, Providence, RI, United States
| | - Zora Djuric
- Department of Family Medicine, University of Michigan, Ann Arbor, MI, United States
| | - Candace McNaughton
- Department of Medicine, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada
| | - David Hutton
- School of Public Health, University of Michigan, Ann Arbor, MI, United States
| | - Lionel P Robert
- School of Information, University of Michigan, Ann Arbor, MI, United States
| | - Sun Young Park
- School of Information, University of Michigan, Ann Arbor, MI, United States
| | - Phillip Levy
- Department of Emergency Medicine and Integrative Biosciences Center, Wayne State University, Detroit, MI, United States
| |
Collapse
|
3
|
Collier DJ, Taylor M, Godec T, Shiel J, James R, Chowdury Y, Ebano P, Monk V, Patel M, Pheby J, Pheby R, Foubister A, David C, Saxena M, Richardson L, Siddle J, Timlin G, Goldsmith P, Deeming N, Poulter NR, Gabe R, McManus RJ, Caulfield MJ. Personalized Antihypertensive Treatment Optimization With Smartphone-Enabled Remote Precision Dosing of Amlodipine During the COVID-19 Pandemic (PERSONAL-CovidBP Trial). J Am Heart Assoc 2024; 13:e030749. [PMID: 38323513 PMCID: PMC11010092 DOI: 10.1161/jaha.123.030749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Accepted: 11/30/2023] [Indexed: 02/08/2024]
Abstract
BACKGROUND The objective of the PERSONAL-CovidBP (Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension: Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic) trial was to assess the efficacy and safety of smartphone-enabled remote precision dosing of amlodipine to control blood pressure (BP) in participants with primary hypertension during the COVID-19 pandemic. METHODS AND RESULTS This was an open-label, remote, dose titration trial using daily home self-monitoring of BP, drug dose, and side effects with linked smartphone app and telemonitoring. Participants aged ≥18 years with uncontrolled hypertension (5-7 day baseline mean ≥135 mm Hg systolic BP or ≥85 mm Hg diastolic BP) received personalized amlodipine dose titration using novel (1, 2, 3, 4, 6, 7, 8, 9 mg) and standard (5 and 10 mg) doses daily over 14 weeks. The primary outcome of the trial was mean change in systolic BP from baseline to end of treatment. A total of 205 participants were enrolled and mean BP fell from 142/87 (systolic BP/diastolic BP) to 131/81 mm Hg (a reduction of 11 (95% CI, 10-12)/7 (95% CI, 6-7) mm Hg, P<0.001). The majority of participants achieved BP control on novel doses (84%); of those participants, 35% were controlled by 1 mg daily. The majority (88%) controlled on novel doses had no peripheral edema. Adherence to BP recording and reported adherence to medication was 84% and 94%, respectively. Patient retention was 96% (196/205). Treatment was well tolerated with no withdrawals from adverse events. CONCLUSIONS Personalized dose titration with amlodipine was safe, well tolerated, and efficacious in treating primary hypertension. The majority of participants achieved BP control on novel doses, and with personalization of dose there were no trial discontinuations due to drug intolerance. App-assisted remote clinician dose titration may better balance BP control and adverse effects and help optimize long-term care. REGISTRATION URL: clinicaltrials.gov. Identifier: NCT04559074.
Collapse
Affiliation(s)
- David J. Collier
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | | | - Thomas Godec
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Julian Shiel
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Rebecca James
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Yasmin Chowdury
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Patrizia Ebano
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Vivienne Monk
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Mital Patel
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Jane Pheby
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Ruby Pheby
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Amanda Foubister
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Clovel David
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | - Manish Saxena
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| | | | | | | | | | | | - Neil R. Poulter
- Imperial College Clinical Trials Unit, School of Public Health, Imperial College LondonLondonUK
| | - Rhian Gabe
- Wolfson Institute of Population HealthQueen Mary University of LondonLondonUK
| | - Richard J. McManus
- Nuffield Department of Primary Care Health SciencesUniversity of OxfordOxfordUK
| | - Mark J. Caulfield
- William Harvey Research InstituteQueen Mary University of LondonLondonUK
| |
Collapse
|
4
|
Hall YN, Anderson ML, McClure JB, Ehrlich K, Hansell LD, Hsu CW, Margolis KL, Munson SA, Thompson MJ, Green BB. Relationship of Blood Pressure, Health Behaviors, and New Diagnosis and Control of Hypertension in the BP-CHECK Study. Circ Cardiovasc Qual Outcomes 2024; 17:e010119. [PMID: 38328915 DOI: 10.1161/circoutcomes.123.010119] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2023] [Accepted: 09/27/2023] [Indexed: 02/09/2024]
Abstract
BACKGROUND Undiagnosed hypertension and uncontrolled blood pressure (BP) are common and contribute to excess cardiovascular morbidity and mortality. We examined whether BP control, changes in BP, and patient behaviors and attitudes were associated with a new hypertension diagnosis. METHODS We performed a post hoc analysis of 323 participants from BP-CHECK (Blood Pressure Checks for Diagnosing Hypertension), a randomized diagnostic study of BP measuring methods in adults without diagnosed hypertension with elevated BP recruited from 12 primary care clinics of an integrated health care system in Washington State during 2017 to 2019. All 323 participants returned a positive diagnostic test for hypertension based on 24-hour ambulatory BP monitoring and were followed for 6 months. We used linear regression to examine the relationships between a new hypertension diagnosis (primary independent variable) and differences in the change in study outcomes from baseline to 6-month. RESULTS Mean age of study participants was 58.3 years (SD, 13.1), 147 (45%) were women, and 253 (80%) were of non-Hispanic White race. At 6 months, 154 of 323 (48%) participants had a new hypertension diagnosis of whom 88 achieved target BP control. Participants with a new hypertension diagnosis experienced significantly larger declines from baseline in BP (adjusted mean difference: systolic BP, -7.6 mm Hg [95% CI, -10.3 to -4.8]; diastolic BP, -3.8 mm Hg [95% CI, -5.6 to -2.0]) compared with undiagnosed peers. They were also significantly more likely to achieve BP control by 6 months compared with undiagnosed participants (adjusted relative risk, 1.5 [95% CI, 1.1 to 2.0]). At 6 months, 101 of 323 participants (31%) with a positive ambulatory BP monitoring diagnostic test remained with undiagnosed hypertension, uncontrolled BP, and no antihypertensive medications. CONCLUSIONS Approximately one-third of participants with high BP on screening and ambulatory BP monitoring diagnostic testing remained with undiagnosed hypertension, uncontrolled BP, and no antihypertensive medications after 6 months. New strategies are needed to enhance integration of BP diagnostic testing into clinical practice. REGISTRATION URL: https://www.clinicaltrials.gov; Unique identifier: NCT03130257.
Collapse
Affiliation(s)
- Yoshio N Hall
- Kidney Research Institute (Y.N.H.), University of Washington, Seattle
- Nephrology Section, VA Puget Sound HCS, Seattle, WA (Y.N.H.)
| | - Melissa L Anderson
- Kaiser Permanente Washington Health Research Institute, Seattle, WA (M.L.A., J.B.M., K.E., L.H., C.H., B.B.G.)
| | - Jennifer B McClure
- Kaiser Permanente Washington Health Research Institute, Seattle, WA (M.L.A., J.B.M., K.E., L.H., C.H., B.B.G.)
- Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA (J.B.M., B.B.G.)
| | - Kelly Ehrlich
- Kaiser Permanente Washington Health Research Institute, Seattle, WA (M.L.A., J.B.M., K.E., L.H., C.H., B.B.G.)
| | - Laurel D Hansell
- Kaiser Permanente Washington Health Research Institute, Seattle, WA (M.L.A., J.B.M., K.E., L.H., C.H., B.B.G.)
| | - Clarissa W Hsu
- Kaiser Permanente Washington Health Research Institute, Seattle, WA (M.L.A., J.B.M., K.E., L.H., C.H., B.B.G.)
| | | | - Sean A Munson
- Department of Human Centered Design and Engineering (S.A.M.), University of Washington, Seattle
| | - Matthew J Thompson
- Clinical Research Scientist, Digital Health Center of Excellence, Google, Seattle, WA (M.J.T.)
| | - Beverly B Green
- Kaiser Permanente Washington Health Research Institute, Seattle, WA (M.L.A., J.B.M., K.E., L.H., C.H., B.B.G.)
- Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA (J.B.M., B.B.G.)
- Washington Permanente Medical Group, Seattle (B.B.G.)
| |
Collapse
|
5
|
Smith JD, Carroll AJ, Sanuade OA, Johnson R, Abramsohn EM, Abbas H, Ahmad FS, Eggleston A, Lazar D, Lindau ST, McHugh M, Mohanty N, Philbin S, Pinkerton EA, Rosul LL, Merle JL, Tedla YG, Walunas TL, Davis P, Kho A. Process of Engaging Community and Scientific Partners in the Development of the CIRCL-Chicago Study Protocol. Ethn Dis 2023; DECIPHeR:18-26. [PMID: 38846735 PMCID: PMC11099531 DOI: 10.18865/ed.decipher.18] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2024] Open
Abstract
Objectives Hypertension affects 1 in 3 adults in the United States and disproportionately affects African Americans. Kaiser Permanente demonstrated that a "bundle" of evidence-based interventions significantly increased blood pressure control rates. This paper describes a multiyear process of developing the protocol for a trial of the Kaiser bundle for implementation in under-resourced urban communities experiencing cardiovascular health disparities during the planning phase of this biphasic award (UG3/UH3). Methods The protocol was developed by a collaboration of faith-based community members, representatives from community health center practice-based research networks, and academic scientists with expertise in health disparities, implementation science, community-engaged research, social care interventions, and health informatics. Scientists from the National Institutes of Health and the other grantees of the Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) Alliance also contributed to developing our protocol. Results The protocol is a hybrid type 3 effectiveness-implementation study using a parallel cluster randomized trial to test the impact of practice facilitation on implementation of the Kaiser bundle in community health centers compared with implementation without facilitation. A central strategy to the Kaiser bundle is to coordinate implementation via faith-based and other community organizations for recruitment and navigation of resources for health-related social risks. Conclusions The proposed research has the potential to improve identification, diagnosis, and control of blood pressure among under-resourced communities by connecting community entities and healthcare organizations in new ways. Faith-based organizations are a trusted voice in African American communities that could be instrumental for eliminating disparities.
Collapse
Affiliation(s)
- Justin D. Smith
- Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT
| | | | - Olutobi A. Sanuade
- Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT
| | | | | | | | - Faraz S. Ahmad
- Northwestern University Feinberg School of Medicine, Chicago, IL
| | | | | | | | - Megan McHugh
- Northwestern University Feinberg School of Medicine, Chicago, IL
| | - Nivedita Mohanty
- Northwestern University Feinberg School of Medicine, Chicago, IL
- AllianceChicago, Chicago, IL
| | - Sarah Philbin
- Northwestern University Feinberg School of Medicine, Chicago, IL
| | - El A. Pinkerton
- University of Chicago Biological Sciences Division, Chicago, IL
| | | | - James L. Merle
- Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT
| | | | | | - Paris Davis
- Total Resource Community Development Organization, Chicago, IL
| | - Abel Kho
- Northwestern University Feinberg School of Medicine, Chicago, IL
| |
Collapse
|
6
|
Tang M, Nakamoto CH, Stern AD, Zubizarreta JR, Marcondes FO, Uscher-Pines L, Schwamm LH, Mehrotra A. Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients With Hypertension : An Observational Study. Ann Intern Med 2023; 176:1465-1475. [PMID: 37931262 DOI: 10.7326/m23-1182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2023] Open
Abstract
BACKGROUND Remote patient monitoring (RPM) is a promising tool for improving chronic disease management. Use of RPM for hypertension monitoring is growing rapidly, raising concerns about increased spending. However, the effects of RPM are still unclear. OBJECTIVE To estimate RPM's effect on hypertension care and spending. DESIGN Matched observational study emulating a longitudinal, cluster randomized trial. After matching, effect estimates were derived from a regression analysis comparing changes in outcomes from 2019 to 2021 for patients with hypertension at high-RPM practices versus those at matched control practices with little RPM use. SETTING Traditional Medicare. PATIENTS Patients with hypertension. INTERVENTION Receipt of care at a high-RPM practice. MEASUREMENTS Primary outcomes included hypertension medication use (medication fills, adherence, and unique medications received), outpatient visit use, testing and imaging use, hypertension-related acute care use, and total hypertension-related spending. RESULTS 192 high-RPM practices (with 19 978 patients with hypertension) were matched to 942 low-RPM control practices (with 95 029 patients with hypertension). Compared with patients with hypertension at matched low-RPM practices, patients with hypertension at high-RPM practices had a 3.3% (95% CI, 1.9% to 4.8%) relative increase in hypertension medication fills, a 1.6% (CI, 0.7% to 2.5%) increase in days' supply, and a 1.3% (CI, 0.2% to 2.4%) increase in unique medications received. Patients at high-RPM practices also had fewer hypertension-related acute care encounters (-9.3% [CI, -20.6% to 2.1%]) and reduced testing use (-5.9% [CI, -11.9% to 0.0%]). However, these patients also saw increases in primary care physician outpatient visits (7.2% [CI, -0.1% to 14.6%]) and a $274 [CI, $165 to $384]) increase in total hypertension-related spending. LIMITATION Lacked blood pressure data; residual confounding. CONCLUSION Patients in high-RPM practices had improved hypertension care outcomes but increased spending. PRIMARY FUNDING SOURCE National Institute of Neurological Disorders and Stroke.
Collapse
Affiliation(s)
- Mitchell Tang
- Harvard Graduate School of Arts and Sciences, Cambridge; and Harvard Business School, Boston, Massachusetts (M.T.)
| | - Carter H Nakamoto
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts (C.H.N.)
| | - Ariel D Stern
- Harvard Business School, Boston; and Harvard-MIT Center for Regulatory Science, Boston, Massachusetts (A.D.S.)
| | - Jose R Zubizarreta
- Department of Health Care Policy, Harvard Medical School, Boston; Department of Biostatistics, Harvard School of Public Health, Boston; and Department of Statistics, Harvard University, Cambridge, Massachusetts (J.R.Z.)
| | - Felippe O Marcondes
- Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts (F.O.M.)
| | | | - Lee H Schwamm
- Stroke Division, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts (L.H.S.)
| | - Ateev Mehrotra
- Department of Health Care Policy, Harvard Medical School, Boston; and Beth Israel Deaconess Medical Center, Boston, Massachusetts (A.M.)
| |
Collapse
|
7
|
Lee DR, Chenoweth M, Chuong LH, Villaflores CW, Cuevas M, Vangala S, Borenstein J, Kwak H, Chima-Melton C, Han M, Skootsky SA, Chan Tack T, Branagan L, Martin H, Gupta R, Phan L, Sanchez MA, Malaak MM, Dermenchyan A, Pearson KN, Altunyan M, Barakat PF, Pablo R, Sarkisian C. A Multisite Electronic Health Record Integrated Remote Monitoring Intervention for Hypertension Improvement: Protocol for a Randomized Pragmatic Comparative Effectiveness Trial. JMIR Res Protoc 2023; 12:e45915. [PMID: 37902819 PMCID: PMC10644190 DOI: 10.2196/45915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Revised: 07/14/2023] [Accepted: 07/19/2023] [Indexed: 10/31/2023] Open
Abstract
BACKGROUND Hypertension is a major contributor to various adverse health outcomes. Although previous studies have shown the benefits of home blood pressure (BP) monitoring over office-based measurements, there is limited evidence comparing the effectiveness of whether a BP monitor integrated into the electronic health record is superior to a nonintegrated BP monitor. OBJECTIVE In this paper, we describe the protocol for a pragmatic multisite implementation of a quality improvement initiative directly comparing integrated to nonintegrated BP monitors for hypertension improvement. METHODS We will conduct a randomized, comparative effectiveness trial at 3 large academic health centers across California. The 3 sites will enroll a total of 660 participants (approximately n=220 per site), with 330 in the integrated BP monitor arm and 330 in the nonintegrated BP control arm. The primary outcome of this study will be the absolute difference in systolic BP in mm Hg from enrollment to 6 months. Secondary outcome measures include binary measures of hypertension (controlled vs uncontrolled), hypertension-related health complications, hospitalizations, and death. The list of possible participants will be generated from a central data warehouse. Randomization will occur after enrollment in the study. Participants will use their assigned BP monitor and join site-specific hypertension interventions. Cross-site learning will occur at regular all-site meetings facilitated by the University of California, Los Angeles Value-Based Care Research Consortium. A pre- and poststudy questionnaire will be conducted to further evaluate participants' perspectives regarding their BP monitor. Linear mixed effects models will be used to compare the primary outcome measure between study arms. Mixed effects logistic regression models will be used to compare secondary outcome measures between study arms. RESULTS The study will start enrolling participants in the second quarter of 2023 and will be completed by the first half of 2024. Results will be published by the end of 2024. CONCLUSIONS This pragmatic trial will contribute to the growing field of chronic care management using remote monitoring by answering whether a hypertension intervention coupled with an electronic health record integrated home BP monitor improves patients' hypertension better than a hypertension intervention with a nonintegrated BP monitor. The outcomes of this study may help health system decision makers determine whether to invest in integrated BP monitors for vulnerable patient populations. TRIAL REGISTRATION ClinicalTrials.gov NCT05390502; clinicaltrials.gov/study/NCT05390502. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) PRR1-10.2196/45915.
Collapse
Affiliation(s)
- David R Lee
- Division of Geriatrics, University of California, Los Angeles, Los Angeles, CA, United States
- Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States
| | - Matthew Chenoweth
- Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States
| | - Linh H Chuong
- Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States
| | - Chad W Villaflores
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
| | - Miguel Cuevas
- Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States
| | - Sitaram Vangala
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
| | - Jeff Borenstein
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
| | - Hannah Kwak
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
| | - Chidinma Chima-Melton
- Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, Los Angeles, CA, United States
| | - Maria Han
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
| | - Samuel A Skootsky
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
- University of California Health, Oakland, CA, United States
| | - Therese Chan Tack
- Division of General Internal Medicine, University of California, San Francisco, San Francisco, CA, United States
| | - Linda Branagan
- Telehealth Resource Center, University of California, San Francisco, San Francisco, CA, United States
| | - Heather Martin
- Department of Pharmacy, University of California Davis Health, Davis, CA, United States
| | - Reshma Gupta
- Department of Internal Medicine, University of California, Davis Health, Sacramento, CA, United States
| | - Linda Phan
- Department of Pharmacy, University of California Davis Health, Davis, CA, United States
| | - Michael A Sanchez
- University of California Office of the President, Oakland, CA, United States
| | - Mina M Malaak
- Ambulatory and Community Practices, University of California, Los Angeles, Los Angeles, CA, United States
| | - Anna Dermenchyan
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
| | - Kandyce N Pearson
- Ambulatory and Community Practices, University of California, Los Angeles, Los Angeles, CA, United States
| | - Marine Altunyan
- Ambulatory and Community Practices, University of California, Los Angeles, Los Angeles, CA, United States
| | - Peter F Barakat
- Ambulatory and Community Practices, University of California, Los Angeles, Los Angeles, CA, United States
| | - Ray Pablo
- University of California Health Data Warehouse, University of California Health, Irvine, CA, United States
| | - Catherine Sarkisian
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
- Geriatrics Research Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States
| |
Collapse
|
8
|
Omboni S. Telemedicine for hypertension management: a paradigm shift from telemonitoring to digital therapeutics. Expert Rev Med Devices 2023; 20:711-714. [PMID: 37496393 DOI: 10.1080/17434440.2023.2242270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 07/04/2023] [Accepted: 07/26/2023] [Indexed: 07/28/2023]
Affiliation(s)
- Stefano Omboni
- Clinical Research Unit, Italian Institute of Telemedicine, Varese, Italy
- Department of Cardiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation
| |
Collapse
|
9
|
Abstract
We stand at a critical juncture in the delivery of health care for hypertension. Blood pressure control rates have stagnated, and traditional health care is failing. Fortunately, hypertension is exceptionally well-suited to remote management, and innovative digital solutions are proliferating. Early strategies arose with the spread of digital medicine, long before the COVID-19 pandemic forced lasting changes to the way medicine is practiced. Highlighting one contemporary example, this review explores salient features of remote management hypertensive programs, including: an automated algorithm to guide clinical decisions, home (as opposed to office) blood pressure measurements, an interdisciplinary care team, and robust information technology and analytics. Dozens of emerging hypertension management solutions are contributing to a highly fragmented and competitive landscape. Beyond viability, profit and scalability are critical. We explore the challenges impeding large-scale acceptance of these programs and conclude with a hopeful look to the future when remote hypertension care will have dramatic impact on global cardiovascular health.
Collapse
Affiliation(s)
- Simin Gharib Lee
- Division of Cardiology, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
| | - Naomi D.L. Fisher
- Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
| |
Collapse
|
10
|
Skolarus LE, Dinh M, Kidwell KM, Lin CC, Buis LR, Brown DL, Oteng R, Giacalone M, Warden K, Trimble DE, Whitfield C, Farhan Z, Flood A, Borgialli D, Montas S, Jaggi M, Meurer WJ. Reach Out Emergency Department: A Randomized Factorial Trial to Determine the Optimal Mobile Health Components to Reduce Blood Pressure. Circ Cardiovasc Qual Outcomes 2023; 16:e009606. [PMID: 37192282 DOI: 10.1161/circoutcomes.122.009606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Accepted: 03/13/2023] [Indexed: 05/18/2023]
Abstract
BACKGROUND Mobile health (mHealth) strategies initiated in safety-net Emergency Departments may be one approach to address the US hypertension epidemic, but the optimal mHealth components or dose are unknown. METHODS Reach Out is an mHealth, health theory-based, 2×2×2 factorial trial among hypertensive patients evaluated in a safety-net Emergency Department in Flint, Michigan. Reach Out consisted of 3 mHealth components, each with 2 doses: (1) healthy behavior text messaging (yes versus no), (2) prompted self-measured blood pressure (BP) monitoring and feedback (weekly versus daily), and (3) facilitated primary care provider appointment scheduling and transportation (yes versus no). The primary outcome was a change in systolic BP from baseline to 12 months. In a complete case analysis, we fit a linear regression model and accounted for age, sex, race, and prior BP medications to explore the association between systolic BP and each mHealth component. RESULTS Among 488 randomized participants, 211 (43%) completed follow-up. Mean age was 45.5 years, 61% were women, 54% were Black people, 22% did not have a primary care doctor, 21% lacked transportation, and 51% were not taking antihypertensive medications. Overall, systolic BP declined after 6 months (-9.2 mm Hg [95% CI, -12.2 to -6.3]) and 12 months (-6.6 mm Hg, -9.3 to -3.8), without a difference across the 8 treatment arms. The higher dose of mHealth components were not associated with a greater change in systolic BP; healthy behavior text messages (point estimate, mmHG=-0.5 [95% CI, -6.0 to 5]; P=0.86), daily self-measured BP monitoring (point estimate, mmHG=1.9 [95% CI, -3.7 to 7.5]; P=0.50), and facilitated primary care provider scheduling and transportation (point estimate, mmHG=0 [95% CI, -5.5 to 5.6]; P=0.99). CONCLUSIONS Among participants with elevated BP recruited from an urban safety-net Emergency Department, BP declined over the 12-month intervention period. There was no difference in change in systolic BP among the 3 mHealth components. Reach Out demonstrated the feasibility of reaching medically underserved people with high BP cared for at a safety-net Emergency Departments, yet the efficacy of the Reach Out mHealth intervention components requires further study. REGISTRATION URL: https://www. CLINICALTRIALS gov; Unique identifier: NCT03422718.
Collapse
Affiliation(s)
- Lesli E Skolarus
- Davee Department of Neurology, Northwestern University, Feinberg School of Medicine Chicago, IL (L.E.S.)
| | - Mackenzie Dinh
- Department of Emergency Medicine (M.D., R.O., D.E.T., C.W., Z.F., A.F., S.M., W.J.M.), University of Michigan, Ann Arbor
| | - Kelley M Kidwell
- Department of Statistics, University of Michigan School of Public Health, Ann Arbor (K.M.K.)
| | - Chun Chieh Lin
- Health Services Research Program (C.C.L.), University of Michigan, Ann Arbor
| | - Lorraine R Buis
- Institute for Healthcare Policy and Innovation (L.R.B.), University of Michigan, Ann Arbor
- Department of Family Medicine (L.R.B.), University of Michigan, Ann Arbor
| | - Devin L Brown
- Department of Neurology (D.L.B., W.J.M.), University of Michigan, Ann Arbor
- Stroke Program (D.L.B., W.J.M.), University of Michigan, Ann Arbor
| | - Rockefeller Oteng
- Department of Emergency Medicine (M.D., R.O., D.E.T., C.W., Z.F., A.F., S.M., W.J.M.), University of Michigan, Ann Arbor
- Department of Emergency Medicine, Hurley Medical Center, Flint, MI (R.O., D.B., M.J.)
| | | | | | - Deborah E Trimble
- Department of Emergency Medicine (M.D., R.O., D.E.T., C.W., Z.F., A.F., S.M., W.J.M.), University of Michigan, Ann Arbor
| | - Candace Whitfield
- Department of Emergency Medicine (M.D., R.O., D.E.T., C.W., Z.F., A.F., S.M., W.J.M.), University of Michigan, Ann Arbor
| | - Zahera Farhan
- Department of Emergency Medicine (M.D., R.O., D.E.T., C.W., Z.F., A.F., S.M., W.J.M.), University of Michigan, Ann Arbor
| | - Adam Flood
- Department of Emergency Medicine (M.D., R.O., D.E.T., C.W., Z.F., A.F., S.M., W.J.M.), University of Michigan, Ann Arbor
| | - Dominic Borgialli
- Department of Emergency Medicine, Hurley Medical Center, Flint, MI (R.O., D.B., M.J.)
| | - Sacha Montas
- Department of Emergency Medicine (M.D., R.O., D.E.T., C.W., Z.F., A.F., S.M., W.J.M.), University of Michigan, Ann Arbor
| | - Michael Jaggi
- Department of Emergency Medicine, Hurley Medical Center, Flint, MI (R.O., D.B., M.J.)
| | - William J Meurer
- Department of Emergency Medicine (M.D., R.O., D.E.T., C.W., Z.F., A.F., S.M., W.J.M.), University of Michigan, Ann Arbor
- Department of Neurology (D.L.B., W.J.M.), University of Michigan, Ann Arbor
- Stroke Program (D.L.B., W.J.M.), University of Michigan, Ann Arbor
| |
Collapse
|
11
|
Error in Figure 1. JAMA Intern Med 2023; 183:278. [PMID: 36689246 PMCID: PMC9871938 DOI: 10.1001/jamainternmed.2022.6633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
12
|
Ferdinand DP, Reddy TK, Wegener MR, Guduri PS, Lefante JJ, Nedunchezhian S, Ferdinand KC. TEXT MY BP MEDS NOLA: A pilot study of text-messaging and social support to increase hypertension medication adherence. AMERICAN HEART JOURNAL PLUS : CARDIOLOGY RESEARCH AND PRACTICE 2023; 26:100253. [PMID: 37712088 PMCID: PMC10500631 DOI: 10.1016/j.ahjo.2023.100253] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/20/2022] [Revised: 01/05/2023] [Accepted: 01/09/2023] [Indexed: 09/16/2023]
Abstract
Study objective Non-Hispanic Black (NHB) adults have high hypertension (HTN) and cardiovascular disease (CVD) burden. Medication nonadherence limits control and self-measured blood pressure (SMBP) improves diagnosis and adherence. This predominantly NHB cohort pilot, via community-clinical linkages, with uncontrolled HTN and low adherence, utilized bidirectional electronic messaging (BEM) with team-care, to assess medication adherence, quality of life, and BP. Setting Academic clinic and community sources. Design Recruitment included: uncontrolled HTN (BP ≥130/80 mm Hg), low adherence (Krousel-Wood Medication Adherence Scale (K-Wood-MAS-4) ≥1 score), and smartphone access. Participants and interventions Participants (N = 36) received validated Bluetooth-enabled BP devices, synced to smartphones, via a secured cloud-based application. Main outcome measures Demographics, adherence scores, Centers for Disease Control and Prevention (CDC) health-related quality of life (HRQOL-14), BP, body mass index (BMI), 8 weeks daily BEM, SMBP and text responses were obtained. Results Age was 58.7 ± 12.8 years; BMI 34.8 ± 7.9; 63.9 % female; 88.9 % self-identified NHB adults; 72.2 % with obesity; 74.3 % with diabetes. K-Wood-MAS-4 adherence composite score improved: 2.19 to 1.58 (median -0.5, p = 0.0001). Systolic BP decreased by 10.5 ± 20.0 mm Hg (median -11.0, p = 0.0027). QOL did not significantly change. Mean 7-day average SBP/DBP differences were -4.94 ± 16.82 (median -3.5, p = 0.0285) and -0.17 ± 7.42 (median 0, p = 0.7001), respectively. Social support with taking BP medication was: "yes" (n = 19); 143.8 mm Hg to 131.5 mm Hg (median -12.5, p = 0.0198) and "no" (n = 14); 142.32 mm Hg to 130.25 mm Hg (median -4.0, p = 0.0771). Conclusions Community-clinical linkages and SMBP with BEM significantly improved medication adherence and SBP without modifying pharmacotherapy.
Collapse
Affiliation(s)
- Daphne P. Ferdinand
- Healthy Heart Community Prevention Project (HHCPP), New Orleans, LA, United States of America
| | - Tina K. Reddy
- Tulane University School of Medicine, New Orleans, LA, United States of America
| | - Madeline R. Wegener
- Tulane University School of Medicine, New Orleans, LA, United States of America
| | - Pavan S. Guduri
- Tulane University School of Medicine, New Orleans, LA, United States of America
| | - John J. Lefante
- Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, United States of America
| | | | - Keith C. Ferdinand
- Tulane University School of Medicine, New Orleans, LA, United States of America
| |
Collapse
|
13
|
Javaid A, Zghyer F, Kim C, Spaulding EM, Isakadze N, Ding J, Kargillis D, Gao Y, Rahman F, Brown DE, Saria S, Martin SS, Kramer CM, Blumenthal RS, Marvel FA. Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology. Am J Prev Cardiol 2022; 12:100379. [PMID: 36090536 PMCID: PMC9460561 DOI: 10.1016/j.ajpc.2022.100379] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Revised: 08/21/2022] [Accepted: 08/28/2022] [Indexed: 11/30/2022] Open
Abstract
Machine learning (ML) refers to computational algorithms that iteratively improve their ability to recognize patterns in data. The digitization of our healthcare infrastructure is generating an abundance of data from electronic health records, imaging, wearables, and sensors that can be analyzed by ML algorithms to generate personalized risk assessments and promote guideline-directed medical management. ML's strength in generating insights from complex medical data to guide clinical decisions must be balanced with the potential to adversely affect patient privacy, safety, health equity, and clinical interpretability. This review provides a primer on key advances in ML for cardiovascular disease prevention and how they may impact clinical practice.
Collapse
|